MAPT and Alzheimer disease: Lower miR-146a expression levels were accompanied by higher levels of tau (AD cases: r = -0.5142, p = 0.0171) and Aβ1–42 (AD cases: r = -0.5364, p = 0.01), and vice versa in our AD group (Fig 4A and 4B).